Centralized monitoring for diversion prevention decreases controlled substance variances
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new centralized monitoring team rapidly improved controlled substance (CS) stewardship by reducing variances and enhancing regulatory compliance. This initiative significantly decreased apparent drug losses and improved accountability within the first year.
Area Of Science
- Healthcare Management
- Pharmacy Practice
- Regulatory Compliance
Background
- Controlled substance (CS) stewardship is crucial for regulatory compliance, preventing diversion, and ensuring patient safety.
- Developing a comprehensive CS diversion prevention program (CSDPP) is time-consuming and resource-intensive.
- Existing diversion management software (DMS) implementation faced challenges with inconsistent variance reconciliation, leading to a significant backlog.
Purpose Of The Study
- To rapidly address controlled substance variances as an initial step toward comprehensive CSDPP development.
- To establish a cost-efficient, centralized multidisciplinary team for monitoring CS variances.
- To strengthen regulatory compliance and promote CS stewardship practices.
Main Methods
- Utilized diversion management software (DMS) across twelve acute care facilities.
- Implemented a centralized multidisciplinary team for daily review of CS variances.
- Compared pre- and post-implementation data on apparent loss variances, drug disposition accountability, and regulatory agency contacts.
Main Results
- Achieved 100% review of CS variances within three months of team creation.
- Reduced apparent loss variances by 41% within one year.
- Improved accountability for drug disposition from 62% to 93% and decreased regulatory reporting by 41%.
Conclusions
- Centralized monitoring of CS variances yields significant benefits within six months, including reduced apparent losses and improved compliance.
- This foundational approach establishes a structure for expanding a comprehensive CSDPP.
- Enhanced monitoring effectively addresses critical aspects of CS stewardship and regulatory requirements.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...